Advertisement

Advertisement

AU:AFP Stock Latest News

AFT Pharmaceuticals posts record growth and strikes key U.S. distribution deal

Company AnnouncementsAFT Pharmaceuticals posts record growth and strikes key U.S. distribution deal

AFT Pharmaceuticals faces change in CFO succession plan

PremiumCompany Announcements

AFT Pharmaceuticals faces change in CFO succession plan

18d ago

AFT Pharmaceuticals Wins Appeal in Pascomer Profit-Sharing Dispute

PremiumCompany Announcements

AFT Pharmaceuticals Wins Appeal in Pascomer Profit-Sharing Dispute

1M ago

AFT Pharmaceuticals Targets Niche Dermatology Upside With New Rapamycin Port Wine Stain Trial

PremiumCompany Announcements

AFT Pharmaceuticals Targets Niche Dermatology Upside With New Rapamycin Port Wine Stain Trial

1M ago

AFT Pharmaceuticals accelerates global hospital push and targets US$6bn injectable market with new R&D deal

PremiumCompany Announcements

AFT Pharmaceuticals accelerates global hospital push and targets US$6bn injectable market with new R&D deal

3M ago

AFT Pharmaceuticals Releases 1H 2026 Performance Overview

PremiumCompany AnnouncementsAFT Pharmaceuticals Releases 1H 2026 Performance Overview

5M ago

AFT Pharmaceuticals Releases Interim Report for H1 2025

Company Announcements

AFT Pharmaceuticals Releases Interim Report for H1 2025

5M ago

AFT Pharmaceuticals Achieves Record Revenue Growth in First Half of 2025

Company Announcements

AFT Pharmaceuticals Achieves Record Revenue Growth in First Half of 2025

5M ago

AFT Pharmaceuticals Announces CFO Transition Amidst Global Expansion

PremiumCompany Announcements

AFT Pharmaceuticals Announces CFO Transition Amidst Global Expansion

5M ago

AFT Pharmaceuticals to Release Half-Year Interim Results on November 20, 2025

PremiumCompany Announcements

AFT Pharmaceuticals to Release Half-Year Interim Results on November 20, 2025

6M ago

AFT Pharmaceuticals Advances Towards $300 Million Revenue Target with Key Clinical Trial Success

PremiumCompany Announcements

AFT Pharmaceuticals Advances Towards $300 Million Revenue Target with Key Clinical Trial Success

7M ago

AFT Pharmaceuticals Director Increases Shareholding

PremiumCompany Announcements

AFT Pharmaceuticals Director Increases Shareholding

7M ago

AFT Pharmaceuticals Secures Shareholder Approval for Key Resolutions

PremiumCompany AnnouncementsAFT Pharmaceuticals Secures Shareholder Approval for Key Resolutions

8M ago

AFT Pharmaceuticals Reports Strong Growth and Global Expansion

Company Announcements

AFT Pharmaceuticals Reports Strong Growth and Global Expansion

8M ago

AFT Pharmaceuticals Targets US$8 Billion Market with Robust R&D Pipeline

Company Announcements

AFT Pharmaceuticals Targets US$8 Billion Market with Robust R&D Pipeline

8M ago

AFT Pharmaceuticals Director Increases Shareholding

PremiumCompany Announcements

AFT Pharmaceuticals Director Increases Shareholding

9M ago

AFT Pharmaceuticals Expands North American Presence with Combogesic IV Launch

PremiumCompany Announcements

AFT Pharmaceuticals Expands North American Presence with Combogesic IV Launch

9M ago

AFT Pharmaceuticals Announces Director’s Shareholding Change Due to Inheritance

PremiumCompany Announcements

AFT Pharmaceuticals Announces Director’s Shareholding Change Due to Inheritance

10M ago

AFT Pharmaceuticals Announces 2025 Annual Shareholders Meeting

PremiumCompany Announcements

AFT Pharmaceuticals Announces 2025 Annual Shareholders Meeting

10M ago

AFT Pharmaceuticals Updates Dividend Announcement

PremiumCompany AnnouncementsAFT Pharmaceuticals Updates Dividend Announcement

10M ago

AFT Pharmaceuticals Updates Dividend Distribution Details

Company Announcements

AFT Pharmaceuticals Updates Dividend Distribution Details

10M ago

AFT Pharmaceuticals Ltd. (AFP) Unveils Dividend Details for Q3: Mark Your Calendar!

Dividends

AFT Pharmaceuticals Ltd. (AFP) Unveils Dividend Details for Q3: Mark Your Calendar!

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >